Holding our breath for Cannabix beta testing news

INK ResearchFebruary 22, 2021
Investors will be holding their breath for news out of a key beta test project at Cannabix Technologies (BLO). Insiders holdings are high and short sellers have almost disappeared.
Get access to daily trading ideas, trending topics, interviews and more!
Please subscribe to Insider Tracking Advantage Ultra

Other INK Research Videos

INK ResearchFebruary 23, 2021
Hemisphere Energy makes its Top 30 debut
Today INK takes a look at micro-cap Hemisphere Energy (HME) which grabs the #2 spot in our February Top 30 Energy report.
INK ResearchFebruary 21, 2021
Insiders bet on kidney disease fighter XORTX Therapeutics
With the broad market facing some headwinds from US Treasury bond issuance, today INK Research looks at a speculative micro-cap biotech play that will depend more on its ability to deliver innovative kidney disease treatments than on the direction of long bond yields.
INK ResearchFebruary 19, 2021
Insiders buy as Theralase gains momentum on trial news
Tiny Theralase (TLT) has some big ambitions. The company is working to apply its laser-activated compounds to treat cancers. Clinical trials are underway and insiders are buying.

Get an Insider Tracking Advantage Ultra subscription for

  • Insider filing email alerts
  • Access to premium INK Research reports
  • Full access to weekly North America Top filer reports
  • and more including access to INK Ultra Money

Only $9.99 per month (plus tax)!